News Release: The first Anti-XIa Antithrombotic Cleared 11-9-26 - The Fritsma Factor

Nov 10 2026

George Fritsma

Click for Bayer’s news release describing the efficacy and safety data for asundexian anti-XIa stroke therapy.

Comments (0)

Anticoagulant Therapy

No comments here.

Leave a Reply Cancel reply

You must be logged in to post a comment.

George Fritsma is a medical laboratory scientist, educator, and author. George is a member of the International Society on Thrombosis and Hemostasis, the International Society for Laboratory Hematology, and the American Society for Clinical Laboratory Science.

Cheat Sheets from George

Quick Question